AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Azino nhb12/9/2023 The treated hemolytic NHB cohort also had significantly longer mean birth hospital stays (4.5 vs. 0%, p = 0.001) than the matched non-NHB cohort. 2.4%, p = 0.003), vacuum extractor affecting newborn (1.9% vs. The treated hemolytic NHB cohort had significantly more birth trauma and hemorrhage (4.5% vs. The matched analysis included 1373 pairs ≥35 weeks GA. The annual NHB prevalence was 29.6 to 31.7% hemolytic NHB, 1.8 to 2.4% treated hemolytic NHB, 0.46 to 0.55%, between 20. They were matched with non-NHB newborns who had neither NHB nor related treatments on the following: delivery hospital/area, gender, delivery route, estimated gestational age (GA), health plan eligibility, and closest date of birth within 5 years. The treated cohort had hemolytic NHB diagnosis and received phototherapy, intravenous immunoglobulin, and/or exchange transfusions. This cohort study used administrative claims from to. This study evaluated the prevalence, clinical characteristics, and economic burden of hemolytic NHB newborns receiving treatment in U.S. Prevalence of hemolytic neonatal hyperbilirubinemia (NHB) is not well characterized, and economic burden at the population level is poorly understood.
0 Comments
Read More
Leave a Reply. |